Consun Pharmaceutical Group Limited (HKG:1681)

HKG:1681 Revenue

Consun Pharmaceutical Group had revenue of 1.78B CNY in the half year ending June 30, 2026, with 40.69% growth. This brings the company's total for the last twelve months to 3.63B, up 11.21% year-over-year. In the year 2025, Consun Pharmaceutical Group had annual revenue of 3.42B with 15.17% growth. That makes Consun Pharmaceutical Group the 10,846th largest company in the world by revenue and 658th in Hong Kong.

• Revenue (ttm): 3.63B CNY
• Revenue Growth: +11.21%
• P/S Ratio: 3.14
• Revenue / Employee: 1.28M CNY
• Employees: 2,847
• Market Cap: 12.71B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

Chart

• Consun Pharmaceutical Segment 2.97B 86.2%
• Yulin Pharmaceutical Segment 473.11M 13.8%

Fiscal year ended Dec 31, 2025 See the full HKG:1681 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.42B	450.12M	15.17%
Dec 31, 2024	2.97B	377.12M	14.56%
Dec 31, 2023	2.59B	250.47M	10.71%
Dec 31, 2022	2.34B	294.99M	14.43%
Dec 31, 2021	2.04B	291.83M	16.65%

Data Source: S&P Global Market Intelligence Last updated: Sep 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error